NCT00911742View on ClinicalTrials.gov

Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Pain
Interventions
DRUG

Tramadol Contramid OAD

1 Tramadol Contramid OAD 200 mg tablet as a single dose

DRUG

Zytram

1 Zytram 200 mg tablet as a single dose

Sponsors

Lead Sponsor

Labopharm Inc.
All Listed Sponsors
lead

Labopharm Inc.

INDUSTRY

NCT00911742 - Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg | Biotech Hunter | Biotech Hunter